跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
VALSARTAN HCT SANDOZ FILM-COATED TABLET 160MG/25MG
Approved
THERAPEUTIC
VALSARTAN HCT SANDOZ FILM-COATED TABLET 160MG/25MG
Novartis Farma S.p.A
🇸🇬 Health Sciences Authority
Approval Date
Mar 22, 2021
Approval ID
62ebbe0ed456b5f2
Company
Novartis Farma S.p.A
Type
Therapeutic
Approval Details
Approval Id
62ebbe0ed456b5f2
Drug Name
VALSARTAN HCT SANDOZ FILM-COATED TABLET 160MG/25MG
Product Name
VALSARTAN HCT SANDOZ FILM-COATED TABLET 160MG/25MG
Approval Number
SIN16127P
Approval Date
2021-03-22
Registrant
NOVARTIS (SINGAPORE) PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
C09DA03
Atc Item Name
valsartan and diuretics
Pharma Manufacturer Name
NOVARTIS (SINGAPORE) PTE LTD
Company Detail Path
/organization/novartis-singapore-pte-ltd
Active Ingredients
HYDROCHLOROTHIAZIDE
25 mg
VALSARTAN
160 mg
HYDROCHLOROTHIAZIDE
25 mg
VALSARTAN
160 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 22, 2021
Approval ID
62ebbe0ed456b5f2
Type
Therapeutic
Back to HSA Approvals
VALSARTAN HCT SANDOZ FILM-COATED TABLET 160MG/25MG - HSA Drug Approval Details
